Detalles de la búsqueda
1.
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.
Oncologist
; 26(3): e394-e402, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219618
2.
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Oncologist
; 26(5): e769-e779, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687747
3.
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).
Mol Cell Proteomics
; 14(10): 2775-85, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26106084
4.
[The significance of biobanks for clinical development]. / Die Bedeutung von Biobanken für die klinische Entwicklung.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 59(3): 344-50, 2016 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-26847235
5.
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Gastric Cancer
; 18(3): 476-84, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038874
6.
Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues.
Proteomics
; 14(4-5): 441-51, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24339433
7.
Detection of truncated HER2 forms in formalin-fixed, paraffin-embedded breast cancer tissue captures heterogeneity and is not affected by HER2-targeted therapy.
Am J Pathol
; 183(2): 336-43, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23727348
8.
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
Eur J Cancer
; 194: 113278, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820553
9.
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.
Cancer Cell
; 41(11): 1963-1971.e3, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890492
10.
Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study.
Lung Cancer
; 167: 41-48, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397297
11.
Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.
Cancers (Basel)
; 14(12)2022 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740574
12.
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
J Pers Med
; 12(1)2022 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35055387
13.
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.
Eur J Cancer
; 114: 128-136, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060925
14.
Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Clin Immunol
; 129(2): 304-12, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18790674
15.
Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab.
Cancer Chemother Pharmacol
; 79(6): 1239-1247, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28497320
16.
89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.
Clin Cancer Res
; 23(20): 6128-6137, 2017 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733442
17.
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.
Clin Cancer Res
; 23(18): 5406-5415, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600476
18.
Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the Seed.
Pancreas
; 45(8): 1167-74, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26825865
19.
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors.
Clin Cancer Res
; 22(4): 877-85, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26463709
20.
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody.
Cancer Chemother Pharmacol
; 75(4): 837-50, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25702049